Kepos Capital’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Kepos Capital’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-29,500	Closed	–	–	382
2023 Q2	$0	Buy	+29,500	New	+$912	﹤0.01%	369
2022 Q4	$3K	Hold	29,500	–	–	﹤0.01%	425
2022 Q3	$6K	Hold	29,500	–	–	﹤0.01%	451
2022 Q2	$7K	Hold	29,500	–	–	﹤0.01%	496
2022 Q1	$23K	Sell	29,500 -95,500	-76%	-$69.9K	﹤0.01%	592
2021 Q4	$150K	Buy	+125,000	New	+$143K	0.01%	446

Kepos Capital's GRNAW Position: Q3 2023 in Review

Kepos Capital sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 29,500 shares.

Kepos Capital first reported a position in GRNAW in Q4 2021 and held it in 6 quarters. The position peaked at $150K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Kepos Capital reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Kepos Capital sold 29,500 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023.
Kepos Capital first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q4 2021 and held it in 6 quarters.
Kepos Capital's GreenLight Biosciences Holdings, PBC Warrant position peaked at $150K in Q4 2021.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Kepos Capital's 13F filing for Q3 2023, filed 14 Nov 2023.